GBIO News and Press, Generation Bio Co. From 11/29/23

2023-11-29 16:27:17 ET A Massachusetts-based %Biotech company captured the attention of the trading community on Wednesday after it was announced that the company will undergo a strategic reorganization to prioritize investment in the development of its cell-targeted lipid nanoparticle ...

2023-11-29 10:16:55 ET More on Generation Bio Generation Bio falls as TD Cowen downgrades after program update Seeking Alpha’s Quant Rating on Generation Bio Historical earnings data for Generation Bio Financial information for Generation Bio F...

Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell types Development of immune-quiet DNA (iqDNA) platform for lead hemophilia A program to continue Strategic reorganization w...

2023-11-10 11:40:37 ET More on Generation Bio Generation Bio falls as TD Cowen downgrades after program update Seeking Alpha’s Quant Rating on Generation Bio Historical earnings data for Generation Bio Financial information for Generation Bio F...

2023-11-10 08:17:54 ET Motus GI Holdings  ( MOTS ) +64% Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu EVS Gastro. Direct Digital Holdings ( DRCT ) +44% Digital Holdings, Inc. (DRCT) - FORM 10-Q | Quarterly Report. AVITA Medical ( RCEL ...

-  Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics -  Proprietary cell-targeted LNP delivery system showed highly selective T cell transduction in humanized mouse model, demons...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Generation Bio Co. (GBIO) is expected to report $-0.51 for Q3 2023

70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle (ctLNP) platform confirmed in non-human primates, demonstrating prolonged circulation an...